Wet Age-Related Macular Degeneration (AMD) – Emerging Therapy, with Unmet Needs and TPP Insights Report – 2025
Wet Age-Related Macular Degeneration (AMD) Emerging Therapy and TPP Insights Thelansis’s “Wet Age-Related Macular Degeneration (AMD) Emerging Therapy, with Unmet Needs and TPP Insights Report – 2025″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profiles (TPPs), trial designs, and KOL insights on key emerging therapies and key drug development opportunities in the indication . Wet Age-Related Macular Degeneration (AMD) Overview Wet Age-Related Macular Degeneration (AMD), also known as neovascular or exudative AMD, is a progressive retinal disorder characterized by the abnormal growth of blood vessels beneath the macula, the central portion of the retina responsible for sharp, detailed vision. These fragile vessels tend to leak blood and fluid, leading to macular scarring and rapid deterioration of central vision, often manifesting as visual distortions, blind spots, or difficulty recognizing faces and reading. Althou...